Other studies determined that HMGB1 blockade alleviates myocardial fibrosis (Wang et al., 2014), possibly interfering with the TLR2-HMGB1 ligand and cardiac autophagy (Wu et al., 2018; Liu et al., 2019). The gene discussed is TLR2; the disease is Myocardial fibrosis.